A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma
Clinical trial NCT01152450 · COMPLETED
Trial details
- NCT number
- NCT01152450
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.